Literature DB >> 8831903

Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethylene: utilization of a PBPK model.

H A el-Masri1, J D Tessari, R S Yang.   

Abstract

Physiologically based pharmacokinetic (PBPK) modeling and gas uptake experiments were utilized to verify the competitive inhibition mechanism of interaction between trichloroethylene (TCE) and 1,1-dichloroethylene (DCE) and to investigate the presence of an interaction threshold between the two chemicals. Initially, gas uptake experiments were conducted on Fischer 344 rats where the initial concentrations of both DCE and TCE were 2000:0, 0:2000, 2000:2000, 1000:0, 1000:1000, and 500:500 ppm, respectively. When the different modes of inhibition interactions (competitive, uncompetitive and noncompetitive) were employed in the PBPK model, the model description of the competitive inhibition provided the best description of the declining concentrations in the gas uptake chamber. Furthermore, to predict the range at which the interaction threshold would be found, the PBPK model included a mathematical description of the percentage of enzyme sites occupied by either chemical in the presence or the absence of the other. By comparing the percentage of occupied sites by one chemical, in the presence of the other, to those sites occupied in the absence of the latter, the PBPK model predicted a range of concentrations (100 ppm or less) of either chemical where the competitive inhibition interaction would not be observed. Consequently, gas uptake experiments were designed where the initial concentration was selected at 2000 ppm for one chemical while the other chemical was set at 100 in one experiment and 50 ppm in another. Under these conditions, the best stimulation to the concentration depletion curves in the gas uptake system of the chemical in the higher concentration was obtained when the PBPK model was run under the assumption of no-interaction. This substantiated the model predictions of the presence of observable interaction only at concentrations higher than 100 ppm.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831903     DOI: 10.1007/s002040050310

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  8 in total

1.  The use of inhalation techniques to assess the kinetic constants of 1,1-dichloroethylene metabolism.

Authors:  M E Andersen; M L Gargas; R A Jones; L J Jenkins
Journal:  Toxicol Appl Pharmacol       Date:  1979-02       Impact factor: 4.219

2.  Vinylidene chloride: its metabolism by hepatic microsomal cytochrome P-450 in vitro.

Authors:  A K Costa; K M Ivanetich
Journal:  Biochem Pharmacol       Date:  1982-06-01       Impact factor: 5.858

3.  Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse.

Authors:  J W Fisher; M L Gargas; B C Allen; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1991-06-15       Impact factor: 4.219

4.  A physiologically based simulation approach for determining metabolic constants from gas uptake data.

Authors:  M L Gargas; M E Andersen; H J Clewell
Journal:  Toxicol Appl Pharmacol       Date:  1986-12       Impact factor: 4.219

5.  Effects of chronic ethanol consumption on hepatic metabolism of aromatic and chlorinated hydrocarbons in rats.

Authors:  A Sato; T Nakajima; Y Koyama
Journal:  Br J Ind Med       Date:  1980-11

6.  Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans.

Authors:  W Dekant; M Metzler; D Henschler
Journal:  Biochem Pharmacol       Date:  1984-07-01       Impact factor: 5.858

7.  A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver.

Authors:  T Nakajima; R S Wang; E Elovaara; S S Park; H V Gelboin; H Vainio
Journal:  Biochem Pharmacol       Date:  1992-01-22       Impact factor: 5.858

8.  Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods.

Authors:  M E Andersen; M L Gargas; H J Clewell; K M Severyn
Journal:  Toxicol Appl Pharmacol       Date:  1987-06-30       Impact factor: 4.219

  8 in total
  7 in total

Review 1.  Application of biologically based computer modeling to simple or complex mixtures.

Authors:  Kai H Liao; Ivan D Dobrev; James E Dennison; Melvin E Andersen; Brad Reisfeld; Kenneth F Reardon; Julie A Campain; Wei Wei; Michael T Klein; Richard J Quann; Raymond S H Yang
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

2.  Some critical issues and concerns related to research advances on toxicology of chemical mixtures.

Authors:  R S Yang
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

Review 3.  Physiological modeling of toxicokinetic interactions: implications for mixture risk assessment.

Authors:  S Haddad; K Krishnan
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

Review 4.  Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.

Authors:  R S Yang; R S Thomas; D L Gustafson; J Campain; S A Benjamin; H J Verhaar; M M Mumtaz
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

5.  Interspecies extrapolation by physiologically based pharmacokinetic modeling.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2015-12-21       Impact factor: 4.068

6.  Evidence for dose-additive effects of pyrethroids on motor activity in rats.

Authors:  Marcelo J Wolansky; Chris Gennings; Michael J DeVito; Kevin M Crofton
Journal:  Environ Health Perspect       Date:  2009-06-08       Impact factor: 9.031

7.  In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane.

Authors:  Ivan D Dobrev; Melvin E Andersen; Raymond S H Yang
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.